ArticleBMC women's health2018
Low uptake of cervical cancer screening among HIV positive women in Gondar University referral hospital, Northwest Ethiopia: cross-sectional study design.
Article in BMC women's health, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 5 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
44 citing papers in PubMed, 5 syntheses or guidelines pooled it, 65 citations in OpenAlex.
- Utilization of cervical cancer screening and its associated factors among women living with HIV in East Africa: a systematic review and meta-analysis.BMC women's health · 2025Pooled it
- Cervical cancer screening utilization among healthcare professionals in Ethiopia: systematic review and meta-analysis.Frontiers in global women's health · 2025Pooled it
- Cervical cancer screening utilization and associated factors among women living with HIV in Ethiopia, 2024: systematic review and meta-analysis.BMC women's health · 2024Pooled it
- Uptake and barriers to cervical cancer screening among human immunodeficiency virus-positive women in Sub Saharan Africa: a systematic review and meta-analysis.BMC women's health · 2023Pooled it
- Cervical cancer screening utilization and predictors among eligible women in Ethiopia: A systematic review and meta-analysis.PloS one · 2021Pooled it
- Article
- Molecular epidemiology of high-risk human papillomavirus infection and its predictive factors among women living with HIV in Northeast Ethiopia: a facility-based cross-sectional study.BMC infectious diseases · 2025Article
- Cervical cancer screening utilization and associated factors among women living with HIV in South West Ethiopia.Scientific reports · 2025Article
- Article
- Uptake and factors associated with cervical cancer screening among women aged 18-49 years at a public hospital in Coastal Kenya.PLOS global public health · 2025Article
- Awareness, attendance, and attitudes toward cervical cancer screening among HIV-positive Chinese women in Yunnan province: a cross-sectional study.BMC women's health · 2024Article
- Cervical cancer screening service utilisation and related factors among women on antiretroviral therapy in public health facilities of Asella town, Ethiopia, cross-sectional study.BMC infectious diseases · 2024Article
- Uptake of cervical cancer screening and associated factors among HIV positive women attending adult art clinic at public hospitals in Addis Ababa, Ethiopia, 2022.BMC women's health · 2024Article
- Article
- Factors associated with utilization of cervical cancer screening services among HIV-positive women aged 18 to 49 years at Lira regional referral hospital, Northern Uganda.BMC women's health · 2024Article
- Drivers of cervical cancer prevention and management in sub-Saharan Africa: a qualitative synthesis of mixed studies.Health research policy and systems · 2024Review
- Uptake of cervical cancer screening and associated factors among human immune virus positive women attending antiretroviral therapy clinic in public health facilities, Northeast Ethiopia, 2022: A cross-sectional study.SAGE open medicine · 2024Article
- Prevalence and predictors of cervical cancer screening among HIV-positive women in rural western Uganda: insights from the health-belief model.BMC cancer · 2023Article
- Usage of cervical cancer screening services among HIV-positive women in Southern Ethiopia: a multicentre cross-sectional study.BMJ open · 2023Article
- An audit of adherence to cervical cancer screening guidelines in a tertiary-level HIV clinic.Southern African journal of HIV medicine · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCervical cancer is one of the leading causes of death in women worldwide. Majority of the cases are found in developing countries. The increasing risk of cervical cancer death and the high prevalence of human papilloma virus (HPV) infection in Human immuno-deficiency virus(HIV) positive women calls for determining the level of premalignant cervical cancer (Ca) screening uptake. So, this study aimed to assess the uptake of cervical cancer screening and its associated factors.
methodsAn institution based cross sectional study was conducted from April to May, 2016, among adult HIV positive women attending care and treatment at Gondar University Referral Hospital. The data were collected using an interviewer administered questionnaire. Bivariate and multivariable logistic regression analyses were used to determine the presence and the degree of association between dependent and independent variables. In the multivariable logistic analysis, a P-value of < 0.05 and odds ratio with a 95% confidence interval were considered to determine independent predictors for the uptake of cervical cancer(Ca) screening.
resultsThe life-time uptake of cervical cancer screening among HIV positive women was 10% (95% Confidence Interval(CI): 7.3-12.8). In multivariable the analysis, women with primary education (Adjusted Odds Ratio(AOR) = 3.92, 95%CI:1.70-8.99), secondary education (AOR = 3.84, 95%CI: 1.50-9.83), and tertiary level education (AOR = 4.16, 95%CI: 1.24-13.98), having a child (AOR = 3.02, 95%CI: 1.23-7.46), diagnosed as HIV positive ten years back or more (AOR = 2.71, 95% CI: 1.06-6.97), and Cell Differentiation 4(CD4) count of less than or equal to 200cell/mm3 (AOR = 5.29, 95% CI: 2.58-10.83) were significantly associated with the uptake of cervical cancer screening.
conclusionIn this study, the uptake of cervical cancer screening was very low. Educational status, parity, length of time after diagnosis as HIV positive, and CD4 count are important predictors of cervical cancer screening. Health care workers and cervical cancer prevention and control program coordinators and implementers need to provide counseling services for all Anti-retroviral Therapy(ART) care attendants. So as to explore the root causes for the low utilization of precancerous stage of cervical Ca screening service, conducting a study on the supply side with a qualitative component is mandatory.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.